Connect with Capsida at ASGCT

Connect with Capsida at ASGCT

May 16-20, 2023
Los Angeles, California

Are you attending the American Society of Gene and Cell Therapy Annual Meeting in LA? If so, we’d love to connect with you. Please come by and say hi, and mark your calendar to attend any of these events.


Capsida Industry-Sponsored Symposium
Unlocking the Potential of Gene Therapy: A Targeted Next Generation Platform

Friday, May 19
Room 511
12 p.m.

*This* is the ASGCT industry symposium you don’t want to miss. Join a group of industry luminaries from Capsida Biotherapeutics, AbbVie, and Prevail Therapeutics for an event on unlocking the potential of gene therapy.

  • Introduction to Capsida Biotherapeutics, Peter Anastasiou, CEO, Capsida BioTherapeutics
  • Realizing the Promise of Next-Generation AAV Gene Therapy; Panel moderated by Susan Catalano, Ph.D., CSO, Capsida Biotherapeutics with Aravind Asokan, Ph.D., Katherine High, M.D., and Viviana Gradinaru, Ph.D.
  • Introduction to Capsida Platform and Pipeline Capabilities, Susan Catalano, Ph.D., CSO, Capsida Biotherapeutics
  • Overview of Engineering Platform, Nick Goeden, Ph.D., Chief Technology Officer, Capsida Biotherapeutics
  • Overview of Pipeline Capabilities, Nick Flytzanis, Ph.D., Chief Research and Innovation Officer, Capsida Biotherapeutics
  • Noninvasive Administration of AAV to Treat CNS Disorders: Prevail/Capsida Collaboration, Sid Kamalakaran, Ph.D., Associate VP Genome Engineering and Modeling, Prevail Therapeutics
  • Preparing for Take Off – A Partnership to Advance Gene Therapies for Age-Related Neurodegenerative Diseases, T Matthew Townsend, Ph.D., Senior Director, AbbVie – Discovery Neuroscience
  • Closing Remarks, Susan Catalano, Ph.D., CSO, Capsida Biotherapeutics (~5 min)
Visit Capsida at the ASGCT Career Fair

May 17-19
Concourse Foyer
3:15-5:15 p.m.

Visit our table and learn about the exciting opportunities to be a part of our DNA.

Learn more